-
BUDGET IMPACT OF INTRODUCING SELUMETINIB FOR SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1: A PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
PREFERENCES OF PEOPLE LIVING WITH HIV FOR INJECTABLE VERSUS ORAL ANTIRETROVIRAL THERAPY (ART): A DISCRETE CHOICE EXPERIMENT (DCE) ACROSS CHINA, US, UK, SPAIN, AND GERMANY
Aug 11, 2026, 17:16 PM -
REPLACING LONG-TERM EFFICACY EXTRAPOLATION WITH REAL-WORLD REGISTRY DATA: AROMA-INFORMED COST-EFFECTIVENESS ANALYSIS OF DUPILUMAB FOR SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
REAL-WORLD CHARACTERISTICS OF MYASTHENIA GRAVIS (MG) AND GENERALIZED MG (MG-RENIRA): A SINGLE-CENTER RETROSPECTIVE STUDY IN POLAND
Aug 11, 2026, 17:16 PM -
CAN AI MATCH THE HUMAN EYE? VALIDATION OF A GENERATIVE AI TOOL FOR NEWCASTLE-OTTAWA QUALITY APPRAISAL IN SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:16 PM -
PSYCHOMETRIC EVALUATION OF THE EQ-5D-5L IN SEPSIS PATIENTS
Aug 11, 2026, 17:16 PM -
ADDRESSING AN UNMET THERAPEUTIC NEED IN GROUP 1 PULMONARY ARTERIAL HYPERTENSION (PAH): CLINICAL OUTCOMES AND ECONOMIC IMPLICATIONS OF PARENTERAL TREPROSTINIL IN THE MEXICAN SOCIAL SECURITY INSTITUTE (IMSS)
Aug 11, 2026, 17:16 PM -
WHEN THE TAIL WAGS THE DOG II: HOW MUCH OF A MATURE OVERALL-SURVIVAL BENEFIT RESTS ON ASSUMPTION (TROPION-BREAST02)
Aug 11, 2026, 17:16 PM -
IMPACT OF REMIBRUTINIB TREATMENT ON WORKPLACE PRODUCTIVITY DUE TO CHRONIC SPONTANEOUS URTICARIA (CSU): A CANADIAN PRIVATE PAYOR PERSPECTIVE
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY AND TREATMENT ALGORITHMS OF GASTRIC CANCER IN TURKIYE: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
INCORPORATING HEALTHCARE PROFESSIONAL OUTCOMES IN RESEARCH PROJECT FUNDING DECISIONS: USEFULNESS OF AN ADAPTED EARLY HTA INSTRUMENT
Aug 11, 2026, 17:16 PM -
REAL-WORLD COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A SAUDI TERTIARY-CENTRE COHORT STUDY
Aug 11, 2026, 17:16 PM -
3-YEAR BUDGET IMPACT OF SWITCHING PATIENTS WITH SCHIZOPHRENIA TO LONG-ACTING PALIPERIDONE (PPLAT) IN THE UAE
Aug 11, 2026, 17:16 PM -
ARE AI-ASSISTED EVIDENCE REVIEWS HTA-READY? A TARGETED LITERATURE REVIEW USING THE ELEVATE-GENAI QUALITY FRAMEWORK
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PUBLIC-FUNDED BIENNIAL LOW-DOSE CT LUNG CANCER SCREENING IN TAIWAN: A RISK-GROUP MARKOV ANALYSIS
Aug 11, 2026, 17:16 PM -
FROM JCA EVIDENCE PACKAGE TO NATIONAL REIMBURSEMENT: HOW EUROPEAN HTA BODIES ASSESS INDIRECT TREATMENT COMPARISONS
Aug 11, 2026, 17:16 PM -
CLINICAL QUALITY INDICATORS IN ORTHOPEDIC CARE IN TURKIYE: A POLICY ANALYSIS AND FRAMEWORK FOR REFINEMENT
Aug 11, 2026, 17:16 PM -
BEYOND CLINICAL BENEFIT: APPROACHES TO INCORPORATING SOCIETAL VALUE IN HTA AND REIMBURSEMENT DECISION-MAKING - A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
MINIMAL SYMPTOM EXPRESSION IN GENERALIZED MYASTHENIA GRAVIS TREATED WITH TRADITIONAL THERAPIES: A REAL-WORLD BENCHMARK FROM MYREALWORLD-MG
Aug 11, 2026, 17:16 PM -
COSMETOVIGILANCE KNOWLEDGE, ATTITUDES, AND HEALTH ANXIETY AMONG UNIVERSITY STUDENTS: A QUESTIONNAIRE-BASED CROSS-SECTIONAL STUDY IN HUNGARY
Aug 11, 2026, 17:16 PM
